NIMVASTID

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug NIMVASTID contains one active pharmaceutical ingredient (API):

1 Rivastigmine
UNII PKI06M3IW0 - RIVASTIGMINE

Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease.

Read about Rivastigmine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NIMVASTID Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06DA03 Rivastigmine N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 09739669, 09739675, 09739681, 09739698, 09739706, 09739712, 09739729, 09739735
Country: EE Ravimiamet Identifier(s): 1420669, 1420670, 1420681, 1420692, 1420704, 1420715, 1420726, 1420737, 1420748, 1420759, 1420760, 1420771, 1420782, 1420793, 1420805, 1420816, 1420827, 1420838, 1420849, 1420850, 1420861, 1420872, 1420883, 1420894, 1420906, 1420917, 1420928, 1420939, 1420940, 1420951, 1420962, 1420973, 1420984, 1420995, 1421008, 1421019, 1421020, 1421031, 1421042, 1421053, 1421064, 1421075, 1421086, 1421097, 1421109, 1470495, 1470507, 1470518, 1470529, 1470675
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 109525004, 109525012, 109525016, 109525018, 109525022, 109525024
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 081681, 139959, 159762, 481345
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 197223, 197231, 197235, 197238
Country: IE Health Products Regulatory Authority Identifier(s): 24472, 24473, 24474, 24475
Country: IT Agenzia del Farmaco Identifier(s): 041673043, 041673106, 041673169, 041673221
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1037908, 1037909, 1037910, 1037911, 1037912, 1037913, 1037914, 1037915, 1037916, 1037917, 1037918, 1037919, 1037920, 1037921, 1037922, 1037923, 1037924, 1037925, 1037926, 1037928, 1037929, 1037930, 1037931, 1037932, 1037933, 1037934, 1037935, 1037936, 1037937, 1037938, 1037939, 1037940, 1037941, 1037942, 1037943, 1037944, 1037995, 1037996, 1037997, 1037998, 1037999, 1038000, 1038001, 1038002, 1038003, 1038004, 1054660, 1054661, 1054662, 1056546
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100209493, 100209518, 100209530, 100209547, 100210941, 100210958, 100210964, 100210970
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W54535001, W54535002, W54535003, W54535004, W54535005, W54535006, W54536001, W54536002, W54536003, W54536004, W54536005, W54536006, W54536007, W54537001, W54537002, W54537003, W54537004, W54537005, W54537006, W54538001, W54538002, W54538003, W54538004, W54538005, W54538006, W54539001, W54539002, W54539003, W54539004, W54539005, W54540001, W54540002, W54540003, W54540004, W54540005, W54541001, W54541002, W54541003, W54541004, W54541005, W54542001, W54542002, W54542003, W54542004, W54542005

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.